BR9808174A - Processo de preparação de derivados de 2-tienil-etilamina - Google Patents

Processo de preparação de derivados de 2-tienil-etilamina

Info

Publication number
BR9808174A
BR9808174A BR9808174-8A BR9808174A BR9808174A BR 9808174 A BR9808174 A BR 9808174A BR 9808174 A BR9808174 A BR 9808174A BR 9808174 A BR9808174 A BR 9808174A
Authority
BR
Brazil
Prior art keywords
general formula
acid
alkali metal
thienyl
metal atom
Prior art date
Application number
BR9808174-8A
Other languages
English (en)
Other versions
BR9808174B1 (pt
Inventor
Bertrand Castro
Jean-Robert Dormoy
Aldo Previero
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of BR9808174A publication Critical patent/BR9808174A/pt
Publication of BR9808174B1 publication Critical patent/BR9808174B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Patente de Invenção: <B>"PROCESSO DE PREPARAçãO DE DERIVADOS DE 2-TIENIL-ETILAMINA"<D>. A presente invenção se refere a um processo para a preparação de derivados 2-tienil-etilamina de fórmula geral: assim como de seus sais de adição de ácido, na qual R representa um átomo de halogênio e R~ 1~ representa um grupamento alquila com C~ 1~-C~ 4~, caracterizado pelo fato de que faz-se reagir um derivado tienilglicídico de fórmula geral: na qual M representa um átomo de metal alcalino ou uma fração de um átomo de metal alcalino-terroso, com um éster de fenilglicina eventualmente sob a forma de um sal de ácido forte, de fórmula geral: na qual R e R~ 1~ têm a mesma significação que precedentemente, na presença de um boridreto de metal alcalino de fórmula geral: X - Y na qual X representa um átomo de metal alcalino e Y representa um grupamento de fórmula: -BH~ 3~CN ou -BH~ (4-W)~Z~ W~ na qual Z representa um resto de ácido carboxílico e eventualmente na presença de um ácido carboxílico com C~ 1~-C~ 4~, o que fornece o composto desejado sob a forma de base livre que é possível tratar se for necessário, com um ácido para obter um sal de adição desse composto.
BRPI9808174-8A 1997-03-05 1998-03-05 processo de preparação de derivados de 2-tienil-etilamina. BR9808174B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9702621A FR2760456B1 (fr) 1997-03-05 1997-03-05 Procede de preparation de derives de 2-thienyl-ethylamine
PCT/FR1998/000441 WO1998039322A1 (fr) 1997-03-05 1998-03-05 Procede de preparation de derives de 2-thienylethylamine

Publications (2)

Publication Number Publication Date
BR9808174A true BR9808174A (pt) 2000-05-16
BR9808174B1 BR9808174B1 (pt) 2010-06-29

Family

ID=9504438

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9808174-8A BR9808174B1 (pt) 1997-03-05 1998-03-05 processo de preparação de derivados de 2-tienil-etilamina.

Country Status (12)

Country Link
US (1) US6080875A (pt)
EP (1) EP0971915B1 (pt)
JP (1) JP4283896B2 (pt)
AT (1) ATE240311T1 (pt)
AU (1) AU6839498A (pt)
BR (1) BR9808174B1 (pt)
CA (1) CA2283126C (pt)
DE (1) DE69814608T2 (pt)
ES (1) ES2200332T3 (pt)
FR (1) FR2760456B1 (pt)
NO (1) NO323613B1 (pt)
WO (1) WO1998039322A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6800759B2 (en) 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
WO2004081015A1 (en) * 2003-03-10 2004-09-23 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
AU2003238664A1 (en) 2003-03-12 2004-09-30 Cadila Healthcare Limited Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate
ATE455778T1 (de) 2003-11-03 2010-02-15 Cadila Healthcare Ltd Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat
WO2006003671A1 (en) * 2004-07-02 2006-01-12 Srinivasa Reddy Battula A process for resolution of methylamino(2-chlorophenyl)acetate
EP1704152A2 (en) * 2004-09-21 2006-09-27 Teva Pharmaceutical Industries Ltd Crystalline clopidogrel hydrobromide and processes for preparation thereof
US20060223845A1 (en) * 2005-02-24 2006-10-05 Eran Turgeman Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
WO2008019053A2 (en) * 2006-08-03 2008-02-14 Teva Pharmaceutical Industries Ltd. Process for preparing clopidogrel bisulphate
EP1980563A1 (en) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
BRPI0803101A2 (pt) * 2007-04-18 2014-04-22 Teva Pharma Processos melhores para preparação de clopidogrel
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US20090264460A1 (en) * 2008-04-21 2009-10-22 Mamta Mishra Clopidogrel pharmaceutical formulations
KR100990949B1 (ko) * 2008-06-09 2010-10-29 엔자이텍 주식회사 클로피도그렐 및 그의 유도체의 제조방법
CN102186858A (zh) * 2008-10-24 2011-09-14 桑多斯股份公司 制备s-氯吡格雷的方法
US8563690B2 (en) * 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
WO2012123958A1 (en) 2011-02-14 2012-09-20 Cadila Healthcare Limited Highly pure salts of clopidogrel free of genotoxic impurities
CN103172527A (zh) * 2011-12-26 2013-06-26 湖北德洲科技发展有限公司 一种制备氯吡格雷合成中间体-邻氯苯甘氨酸甲酯的方法
WO2014012942A1 (en) * 2012-07-17 2014-01-23 Sanofi Use of vegfr-3 inhibitors for treating hepatocellular carcinoma
CN106748853B (zh) * 2016-11-25 2018-12-28 河南普瑞医药科技有限公司 一种（s）-邻氯苯甘氨酸甲酯盐酸盐的制备方法
CN115784914B (zh) * 2022-12-20 2023-05-12 石家庄中硕科技有限公司 一种邻氯苯甘氨酸的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT50679A (en) * 1986-04-24 1990-03-28 Proizv Ob Mekh Robotizatsii N Vertical centrifugal pig machine
FR2624860B1 (fr) * 1987-12-18 1990-06-01 Sanofi Sa Procede de preparation de la n-(chloro-2 benzyl) (thienyl-2)-2 ethylamine
ZA896260B (en) * 1988-08-22 1990-05-30 Merrell Dow Pharma Phenylalkylthiophenes and related compounds
FR2664276B1 (fr) * 1990-07-04 1992-10-23 Sanofi Sa Derive thienyl-2 glycidique, son procede de preparation et son utilisation comme intermediaire de synthese.
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.

Also Published As

Publication number Publication date
US6080875A (en) 2000-06-27
EP0971915B1 (fr) 2003-05-14
FR2760456B1 (fr) 2000-05-12
EP0971915A1 (fr) 2000-01-19
NO994304D0 (no) 1999-09-03
NO994304L (no) 1999-11-03
JP4283896B2 (ja) 2009-06-24
BR9808174B1 (pt) 2010-06-29
CA2283126C (fr) 2008-09-02
ATE240311T1 (de) 2003-05-15
DE69814608T2 (de) 2004-04-01
FR2760456A1 (fr) 1998-09-11
CA2283126A1 (fr) 1998-09-11
ES2200332T3 (es) 2004-03-01
WO1998039322A1 (fr) 1998-09-11
DE69814608D1 (de) 2003-06-18
JP2001513806A (ja) 2001-09-04
NO323613B1 (no) 2007-06-18
AU6839498A (en) 1998-09-22

Similar Documents

Publication Publication Date Title
BR9808174A (pt) Processo de preparação de derivados de 2-tienil-etilamina
CO4820391A1 (es) Compuestos hipolipidemicos de benzotiazepina
KR830006332A (ko) 의약품류 제조용 신규의 헤파린 에스테르류 제조방법
PT787726E (pt) Novo composto, processo para a sua producao e agente tumoral
HUP0301427A2 (hu) Fotokemoterápiában alkalmazható fotoszenzitizáló, 5-aminolevulinsavészterek azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
KR910021366A (ko) 4-(4-알콕시페닐)-2-부틸아민 유도체 및 그의 제조방법
KR850000033A (ko) 8-클로로-1,5-벤조티아제핀 유도체의 제조방법
BRPI0415220A (pt) processo de produção de amida carboxìlica e derivados da mesma
KR860004049A (ko) 퀴놀론카복실산 유도체의 제조방법
ES2040366T3 (es) Procedimiento de preparacion de nuevos derivados de 1-(bencilpiperidino)2-propanol.
ATE268751T1 (de) Biphenylamidin-derivate
BRPI0418047A (pt) processo para a preparação de derivados de piridina
IT1203971B (it) Derivati di 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro applicazione come medicamenti
FI913067A0 (fi) Bisfosfonsyraderivat, deras framstaellning och anvaendning.
BR1100207A (pt) Processo para a preparação de derivados de hexa-hidroazepina
KR900011735A (ko) 암화학요법제로서의 3-페닐-5,6-디하이드로벤즈[c]아크리딘-7-카복실산 및 관련 화합물
ES2089097T3 (es) Procedimiento para la fabricacion de derivados de bencilftalacinona y sales de la misma.
PT99043A (pt) Processo para a preparacao de composicoes biocidas contendo derivados de 4,5-polimetileno-4-isotiazolin-3-onas
EA200500212A1 (ru) Способ получения енамидопроизводных фенилаланина
ES2059451T3 (es) Derivados de naftotiazepina y su procedimiento de preparacion.
DE3268984D1 (en) Imidazolylcarboxylic acids, their derivatives and production
GB1028237A (en) Alpha-adamantanoxy carboxylic acid and derivatives
AR021563A1 (es) Proceso de preparacion de derivados de piridazi-3-non
BR9809726A (pt) Processo para preparar 3,4 - dehidroprolinas quirais
BR0013100A (pt) Processo para a preparação de um composto de 2-arilvinil alquil éter

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS (FR)

Free format text: ALTERADO DE: SANOFI-SYNTHELABO

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT. CL: C07D 333/20; B01J 31/14.

Ipc: C07D 333/20 (2008.04), B01J 31/14 (2008.04)

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/06/2010, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2307 DE 24-03-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.